IL2 and myeloid sarcoma: Patients with MS have elevated levels of IL-2 in their cerebrospinal fluid (CSF) and sera and IL-2-deficient mice are more resistant to experimental autoimmune encephalitis (EAE) than their heterozygote and wild-type counterparts [12].